OTC sunscreens rule
This article was originally published in The Tan Sheet
Executive Summary
FDA will continue to accept comments on its proposed rule to amend the final monograph for over-the-counter sunscreen products until Dec. 26, the agency announces in a Nov. 28 Federal Register notice. The agency pushed the deadline back by one month in response to requests from parties wanting additional time to submit comments. FDA issued the proposed rule Aug. 23, amending the final monograph to include UVA ray protection standards including in vivo and in vitro tests (1"The Tan Sheet" Aug. 27, 2007, p. 3). The final monograph was issued in 1999, but has consistently been stayed due to pressure from industry...
You may also be interested in...
Sunscreen Proposed Rule May Create UVA Protection Marketing Opportunity
FDA's proposed rule amending its final monograph on sunscreens to include UVA ray protection standards could create new marketing opportunities for manufacturers (see chart: "1Selected Proposed Changes To OTC Sunscreen Monograph")
Finance Watch: Lilly, Fosun Reveal Strategic Investments In Start-Ups, Growth-Stage Firms
Private Company Edition: Lilly will open a third accelerator, this time in San Diego, and Fosun partnered with Treehill to help later-stage firms get over the finish line. Also, Flagship – after recent UK investments – signals its next fund will total $3bn. ArrivoBio and Alto Neuroscience raised $45m each.
News We’re Watching: Biden Moves To Strengthen Supply Chain; More Medtech-Related Prosecutions; $5.5M Sepsis Grant For Siemens
This week, the Biden administration announced a new council on supply chain resilience that includes health care goals; an apparent enforcement surge against device fraud continued; Siemens won a $5.5m grant to develop a better sepsis test; and the FDA proposed new classifications for wound care products.